跳至主要内容
临床试验/NCT04767724
NCT04767724已完成4 期

A Prospective Randomized Controlled Clinical Trial Comparing the Extracorporeal Shock Wave and Local Corticosteroid Injection for Carpal Tunnel Syndrome

Chinese Medical Association1 个研究点 分布在 1 个国家目标入组 55 人开始时间: 2018年4月10日最近更新:
适应症
干预措施

试验速览

阶段
4 期
状态
已完成
入组人数
55
试验地点
1
主要终点
The amplitude of the median sensory nerve action potential

研究概览

简要总结

This RCT is to investigate the clinical effect of extracorporeal shock wave therapy (ESWT) compared to the local corticosteroid injection (LCI) in managing mild to moderate carpal tunnel syndrome (CTS).

详细描述

To investigate the effect of extracorporeal shock wave therapy (ESWT) compared to the local corticosteroid injection (LCI) in managing mild to moderate carpal tunnel syndrome (CTS). About 50-60 patients with mild to moderate CTS are supposed to be randomly allocated into either ESWT group or LCI group. The outcomes include the visual analog scale (VAS), the Boston Carpal Tunnel Questionnaire (BCTQ), and nerve conduction study at baseline and at 3 weeks, 9 weeks, 12 weeks, 6 months, and 12 months after the treatments.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Single (Participant)

入排标准

年龄范围
18 Years 至 60 Years(Adult)
性别
All
接受健康志愿者
否

入选标准

  • •The patients aged ≥18 years
  • •Should present a new episode of CTS with symptoms lasting for ≥ six weeks
  • •Symptoms include wrist pain, numbness, and paraesthesia on the hands
  • •Tested postive by the Phalen test and Tinel test
  • •Electrodiagnostically diagnosed with mild to moderate CTS

排除标准

  • •A lack of consent information
  • •A history of a CTS surgery or LCI in the carpal tunnel
  • •Asystemic disease that may interfere with the study

研究组 & 干预措施

Extracorporeal shock wave

Experimental

Participants received three ESWT sessions once per week for three consecutive weeks. The probe of the ESWT machine (FT-174; Swiss Dolor Class; Switzerland) was placed perpendicularly on the patient's palm over the median nerve on the carpal tunnel after application of the ultrasound gel as a coupling agent. Afterward, the ESWT was administered with 1000 shots, 1.5 bar of pressure, and a frequency of 6 Hz

干预措施: Extracorporeal shock wave (Device)

Local corticosteroid injection

Active Comparator

A single injection of one mL (40 mg) of betamethasone into the region surrounding the median nerve.

干预措施: Extracorporeal shock wave (Device)

结局指标

主要结局

The amplitude of the median sensory nerve action potential

时间窗: At 12 months after the treatments

The amplitude of the median sensory nerve action potential is used to assess the function status of the median sensory nerve. The value ranges from 0 μV. The higher value means the better function status of the nerve.

Boston Carpal Tunnel Questionnaire (BCTQ)

时间窗: At 12 months after the treatments

Boston Carpal Tunnel Questionnaire (BCTQ) is the most widely used self-administered outcome scale in patients with carpal tunnel syndrome (CTS) for assessing patients' perceived symptom severity and functional status. The score ranges from 19 to 95. The higher score means a worse status of CTS.

The distal latency of the median compound motor action potential (CMAP)

时间窗: At 12 months after the treatments

The distal latency of the median compound motor action potential (CMAP) is used to assess the function status of the median compound motor nerve. The value ranges from 0 ms. The less value means the quicker conduction of the action potential and the better function status of the nerve.

The amplitude of the median compound motor action potential

时间窗: At 12 months after the treatments

The amplitude of the median compound motor action potential is used to assess the function status of the median compound motor nerve. The value ranges from 0 mV. The higher value means the better function status of the nerve.

Visual Analog Scale (VAS)

时间窗: At 12 months after the treatments

The Visual Analog Scale (VAS) is frequently used as a tool to measure the degree of the pain felt by the participants. The score ranges from 0 to 10. The higher score means a higher degree of the pain.

The peak latency of the median sensory nerve action potential (SNAP)

时间窗: At 12 months after the treatments

The peak latency of the median sensory nerve action potential (SNAP) is used to assess the function status of the median sensory nerve. The value ranges from 0 ms. The less value means the quicker conduction of the action potential and the better function status of the nerve.

Visual Analog Scale (VAS)

时间窗: At baseline (before the treatment)

The Visual Analog Scale (VAS) is frequently used as a tool to measure the degree of the pain felt by the participants. The score ranges from 0 to 10. The higher score means a higher degree of the pain.

Visual Analog Scale (VAS)

时间窗: At 6 months after the treatments

The Visual Analog Scale (VAS) is frequently used as a tool to measure the degree of the pain felt by the participants. The score ranges from 0 to 10. The higher score means a higher degree of the pain.

Boston Carpal Tunnel Questionnaire (BCTQ)

时间窗: At baseline (before the treatment)

Boston Carpal Tunnel Questionnaire (BCTQ) is the most widely used self-administered outcome scale in patients with carpal tunnel syndrome (CTS) for assessing patients' perceived symptom severity and functional status. The score ranges from 19 to 95. The higher score means a worse status of CTS.

Boston Carpal Tunnel Questionnaire (BCTQ)

时间窗: At 6 months after the treatments

Boston Carpal Tunnel Questionnaire (BCTQ) is the most widely used self-administered outcome scale in patients with carpal tunnel syndrome (CTS) for assessing patients' perceived symptom severity and functional status. The score ranges from 19 to 95. The higher score means a worse status of CTS.

The peak latency of the median sensory nerve action potential (SNAP)

时间窗: At baseline (before the treatment)

The peak latency of the median sensory nerve action potential (SNAP) is used to assess the function status of the median sensory nerve. The value ranges from 0 ms. The less value means the quicker conduction of the action potential and the better function status of the nerve.

The peak latency of the median sensory nerve action potential (SNAP)

时间窗: At 6 months after the treatments

The peak latency of the median sensory nerve action potential (SNAP) is used to assess the function status of the median sensory nerve. The value ranges from 0 ms. The less value means the quicker conduction of the action potential and the better function status of the nerve.

The amplitude of the median sensory nerve action potential

时间窗: At baseline (before the treatment)

The amplitude of the median sensory nerve action potential is used to assess the function status of the median sensory nerve. The value ranges from 0 μV. The higher value means the better function status of the nerve.

The amplitude of the median sensory nerve action potential

时间窗: At 6 months after the treatments

The amplitude of the median sensory nerve action potential is used to assess the function status of the median sensory nerve. The value ranges from 0 μV. The higher value means the better function status of the nerve.

The distal latency of the median compound motor action potential (CMAP)

时间窗: At baseline (before the treatment)

The distal latency of the median compound motor action potential (CMAP) is used to assess the function status of the median compound motor nerve. The value ranges from 0 ms. The less value means the quicker conduction of the action potential and the better function status of the nerve.

The distal latency of the median compound motor action potential (CMAP)

时间窗: At 6 months after the treatments

The distal latency of the median compound motor action potential (CMAP) is used to assess the function status of the median compound motor nerve. The value ranges from 0 ms. The less value means the quicker conduction of the action potential and the better function status of the nerve.

The amplitude of the median compound motor action potential

时间窗: At baseline (before the treatment)

The amplitude of the median compound motor action potential is used to assess the function status of the median compound motor nerve. The value ranges from 0 mV. The higher value means the better function status of the nerve.

The amplitude of the median compound motor action potential

时间窗: At 6 months after the treatments

The amplitude of the median compound motor action potential is used to assess the function status of the median compound motor nerve. The value ranges from 0 mV. The higher value means the better function status of the nerve.

次要结局

未报告次要终点

研究者

申办方类型
Network
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验